Efficacy and tolerability of paroxetine, fluvoxamine and milnacipran in depression : A result of two pooled open label randomized controlled trial

被引：0
|
作者：
Kato, M. [1 ]
Wakeno, M. [1 ]
Takekita, Y. [1 ]
Okugawa, G. [1 ]
Sakai, S. [1 ]
Kinoshita, T. [1 ]
机构：
[1] Kansai Med Univ, Moriguchi, Osaka 570, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-09-027
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [21] A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder
    Uchida, H
    Takeuchi, H
    Nomura, K
    Suzuki, T
    Watanabe, K
    Kashima, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A16 - A16
  • [22] A Open-Label, Prospective Randomized Trial To Compare Tolerability and Outcome for Two Formulations of Mycophenolate.
    Qazi, Yasir A.
    Mateo, Rod
    Romero, Chris
    Qazi, Suhail
    Smogorzewski, Mirek
    Shah, Tariq
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 432 - 432
  • [23] Effect of Adding Milnacipran to Pregabalin for the Management of Fibromyalgia: A Randomized, Open-Label, Controlled Study
    Farmer, Mildred V.
    Trugman, Joel M.
    Wang, Yong
    Gendreau, R. Michael
    NEUROLOGY, 2011, 76 (09) : A192 - A192
  • [24] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, Uri
    Carmeli, Gal
    Chalamish, Yossi
    Braw, Yoram
    Kirsch, Irving
    Shefet, Daphna
    Krieger, Israel
    Mendlovic, Shlomo
    Bloch, Yuval
    Lichtenberg, Pesach
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 707 - 710
  • [25] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [26] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [27] The Efficacy and Tolerability of Milnacipran 100 mg/day Monotherapy for the Management of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Lesley M.
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    NEUROLOGY, 2010, 74 (09) : A187 - A187
  • [28] Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescents
    Parellada, M. J.
    Moreno, D.
    Ruiz-Sancho, A.
    Medina, O.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S377 - S378
  • [29] Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: Preliminary open-label study
    Sato, Shinji
    Yamakawa, Yuriko
    Terashima, Yasushi
    Ohta, Hitoshi
    Asada, Takashi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (05) : 584 - 589
  • [30] Clinical Efficacy of Azithromycin in Patients With Severe Sepsis: Open Label Pilot Randomized Controlled Trial
    Restrepo, Marcos
    Faverio, Paola
    Arango, Alejandro
    Sibila, Oriol
    Mortensen, Eric
    Waterer, Grant
    Wunderink, Richard
    Anzueto, Antonio
    CHEST, 2014, 145 (03)
12345